Outcomes of lung transplantation using three different cytomegalovirus prophylactic regimens

Transplant Proc. 1993 Feb;25(1 Pt 2):1434-5.

Authors

J R Maurer¹, G Snell, A deHoyos, S Kesten, T Winton

Affiliation

¹ Toronto Lung Transplant Program, University of Toronto, Ontario, Canada.

PMID: 8382872

No abstract available

Publication types

Clinical Trial
Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Actuarial Analysis
Acyclovir / therapeutic use*
Combined Modality Therapy
Cytomegalovirus
Cytomegalovirus Infections / physiopathology
Cytomegalovirus Infections / prevention & control*
Humans
Immunization, Passive*
Immunoglobulins
Immunoglobulins, Intravenous
Lung Transplantation*
Survival Analysis
Treatment Outcome

Substances

Immunoglobulins
Immunoglobulins, Intravenous
cytomegalovirus-specific hyperimmune globulin
Acyclovir